Complete financial analysis of Amoy Diagnostics Co., Ltd. (300685.SZ) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Amoy Diagnostics Co., Ltd., a leading company in the Medical – Diagnostics & Research industry within the Healthcare sector.
You may be interested
- PT Era Mandiri Cemerlang Tbk (IKAN.JK) Income Statement Analysis – Financial Results
- Shanghai Pharmaceuticals Holding Co., Ltd (601607.SS) Income Statement Analysis – Financial Results
- LiqTech International, Inc. (LIQT) Income Statement Analysis – Financial Results
- Sakol Energy Public Company Limited (SKE.BK) Income Statement Analysis – Financial Results
- eFotoXpress, Inc. (EFOT) Income Statement Analysis – Financial Results
Amoy Diagnostics Co., Ltd. (300685.SZ)
About Amoy Diagnostics Co., Ltd.
Amoy Diagnostics Co., Ltd., a diagnostic company, focuses on molecular diagnostics for oncology precision medicine in China and internationally. The company offers NGS, real-time PCR, FISH, and extraction assays. Amoy Diagnostics Co., Ltd. was founded in 2008 and is based in Xiamen, China.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1.04B | 842.18M | 917.03M | 728.39M | 578.36M | 439.03M | 330.37M | 252.99M | 176.88M | 106.81M | 74.38M | 38.15M |
| Cost of Revenue | 167.29M | 147.81M | 143.27M | 94.94M | 55.71M | 39.36M | 25.24M | 23.22M | 12.12M | 6.21M | 5.03M | 3.41M |
| Gross Profit | 876.21M | 694.37M | 773.76M | 633.45M | 522.65M | 399.67M | 305.13M | 229.76M | 164.76M | 100.60M | 69.35M | 34.74M |
| Gross Profit Ratio | 83.97% | 82.45% | 84.38% | 86.97% | 90.37% | 91.04% | 92.36% | 90.82% | 93.15% | 94.19% | 93.23% | 91.06% |
| Research & Development | 203.22M | 174.53M | 156.12M | 115.11M | 93.75M | 78.34M | 50.83M | 49.31M | 33.78M | 20.40M | 12.98M | 0.00 |
| General & Administrative | 41.84M | 42.53M | 54.78M | 87.91M | 47.88M | 10.89M | 10.00M | 6.70M | 18.61M | 6.21M | 19.78M | 13.63M |
| Selling & Marketing | 319.64M | 303.78M | 302.91M | 233.56M | 220.27M | 171.90M | 129.77M | 108.37M | 77.18M | 47.75M | 31.00M | 16.77M |
| SG&A | 361.48M | 346.31M | 357.69M | 321.47M | 268.16M | 182.80M | 139.76M | 115.07M | 95.79M | 53.96M | 50.78M | 30.40M |
| Other Expenses | 0.00 | -1.58M | -1.26M | -1.44M | -1.10M | -1.55M | 579.02K | 13.22M | 5.46M | 6.02M | 9.82M | 5.86M |
| Operating Expenses | 574.97M | 524.25M | 508.90M | 415.04M | 365.74M | 263.24M | 194.52M | 179.94M | 146.67M | 82.06M | 51.60M | 30.88M |
| Cost & Expenses | 742.26M | 672.06M | 652.17M | 509.98M | 421.45M | 302.60M | 219.77M | 203.16M | 158.79M | 88.27M | 56.63M | 34.29M |
| Interest Income | 19.17M | 6.11M | 3.13M | 6.79M | 13.23M | 2.60M | 1.26M | 632.17K | 439.66K | 69.22K | 0.00 | 0.00 |
| Interest Expense | 1.57M | 993.05K | 375.16K | 859.08K | 50.25K | 605.77K | 257.91K | 568.60K | 1.48M | 615.66K | 226.10K | 0.00 |
| Depreciation & Amortization | 56.55M | 53.24M | 39.67M | 28.31M | 25.49M | 20.73M | 17.36M | 16.46M | 11.95M | 5.68M | 4.44M | 3.39M |
| EBITDA | 352.60M | 350.61M | 291.26M | 228.89M | 193.34M | 162.70M | 124.95M | 90.35M | 41.15M | 30.71M | 22.19M | 7.24M |
| EBITDA Ratio | 33.79% | 29.34% | 32.52% | 32.63% | 32.72% | 37.81% | 37.94% | 35.90% | 22.38% | 28.75% | 30.96% | 19.74% |
| Operating Income | 301.25M | 287.66M | 253.24M | 202.15M | 162.45M | 143.92M | 106.35M | 59.95M | 19.31M | 16.90M | 16.64M | 3.71M |
| Operating Income Ratio | 28.87% | 34.16% | 27.61% | 27.75% | 28.09% | 32.78% | 32.19% | 23.70% | 10.92% | 15.83% | 22.37% | 9.73% |
| Total Other Income/Expenses | -6.39M | -1.58M | -1.26M | -1.44M | -1.10M | -1.55M | 579.02K | 11.01M | 5.29M | 6.02M | 9.75M | 5.86M |
| Income Before Tax | 294.86M | 286.08M | 251.98M | 200.71M | 161.35M | 142.38M | 106.93M | 73.05M | 24.60M | 22.92M | 26.39M | 9.57M |
| Income Before Tax Ratio | 28.26% | 33.97% | 27.48% | 27.56% | 27.90% | 32.43% | 32.37% | 28.88% | 13.91% | 21.46% | 35.48% | 25.08% |
| Income Tax Expense | 33.37M | 21.79M | 12.95M | 20.38M | 25.88M | 15.64M | 12.87M | 7.59M | 6.11M | 3.78M | 4.34M | 1.60M |
| Net Income | 261.48M | 263.74M | 239.57M | 180.33M | 135.47M | 126.74M | 94.07M | 67.03M | 21.09M | 19.14M | 22.05M | 7.97M |
| Net Income Ratio | 25.06% | 31.32% | 26.12% | 24.76% | 23.42% | 28.87% | 28.47% | 26.50% | 11.92% | 17.92% | 29.65% | 20.90% |
| EPS | 0.66 | 0.67 | 0.60 | 0.46 | 0.52 | 0.33 | 0.28 | 0.23 | 0.07 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | 0.66 | 0.67 | 0.60 | 0.45 | 0.52 | 0.33 | 0.28 | 0.23 | 0.07 | 0.00 | 0.00 | 0.00 |
| Weighted Avg Shares Out | 396.19M | 393.65M | 395.63M | 395.84M | 259.42M | 388.80M | 334.18M | 290.88M | 292.78M | 0.00 | 0.00 | 0.00 |
| Weighted Avg Shares Out (Dil) | 396.19M | 393.65M | 399.29M | 400.73M | 259.42M | 388.85M | 334.18M | 290.88M | 292.78M | 0.00 | 0.00 | 0.00 |
No news found for: 300685.SZ
Source: https://incomestatements.info
Category: Stock Reports